Bluejay Diagnostics (BJDX) Return on Capital Employed Growth (3y) (2024 - 2026)
Bluejay Diagnostics (BJDX) Return on Capital Employed Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | - |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 370.00 |
| 10 | Bluejay Diagnostics | 1.93 Mn | 1.93 Mn | - | 2,395.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,395.00 |
| Mar 31, 2026 | -4,955.00 |
| Dec 31, 2025 | -7,049.00 |
| Sep 30, 2025 | -10,148.00 |
| Jun 30, 2025 | -10,474.00 |
| Mar 31, 2025 | -11,623.00 |
| Dec 31, 2024 | -7,944.00 |